Jeff L. Vacirca is Director at SPECTRUM PHARMACEUTICALS INC (SPPI). They have made 6 open-market trades across 4 companies since 2017, most recently 2026-08-14.
CIK 0001724161
6 open-market purchases totalling $1.1M since 2017, never a sale. Across 6 scored buys the stock is up 32.6% at ninety days, and 30.7 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| ASRT | 151,159 | $3.6M |
| CAI | 62,863 | $1.9M |
| SPPI | 270,244 | $278K |
| ODT | 23,231 | $26K |
| Total | $5.8M |
Shares reported on the most recent Form 4, priced at the 2026-08-14 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 67% | 83% |
| Avg Move | +7.1% | +17.7% | +32.6% |
| Alpha | +6.2% | +16.2% | +30.7% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CAI | BUY | 2026-05-11 | 2026-05-12 | $16.15 | $501K | -3.8% | +11.2% | +44.9% |
| ASRT | BUY | 2024-06-11 | 2024-06-12 | $1.11 | $11K | +15.4% | +59.6% | +19.2% |
| SPPI | BUY | 2022-11-30 | 2022-12-02 | $0.45 | $23K | -0.2% | -15.0% | +101.2% |
| ODT | BUY | 2019-06-26 | 2019-06-28 | $26.00 | $500K | -0.7% | +5.2% | -29.8% |
| ODT | BUY | 2019-03-04 | 2019-03-07 | $17.00 | $51K | +26.2% | +45.4% | +52.0% |
| ODT | BUY | 2017-12-12 | 2017-12-14 | $23.30 | $23K | +5.7% | -0.1% | +8.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.